Danaher Co. (NYSE:DHR) Holdings Lifted by Sigma Planning Corp

Sigma Planning Corp increased its holdings in Danaher Co. (NYSE:DHR) by 6.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,454 shares of the conglomerate’s stock after acquiring an additional 489 shares during the period. Sigma Planning Corp’s holdings in Danaher were worth $2,269,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in DHR. Camden National Bank grew its holdings in Danaher by 1.1% in the 4th quarter. Camden National Bank now owns 5,817 shares of the conglomerate’s stock valued at $1,292,000 after buying an additional 65 shares during the last quarter. E Fund Management Co. Ltd. acquired a new stake in shares of Danaher during the 1st quarter worth approximately $354,000. Quilter Plc grew its holdings in shares of Danaher by 6.3% during the 1st quarter. Quilter Plc now owns 13,894 shares of the conglomerate’s stock worth $3,128,000 after purchasing an additional 825 shares in the last quarter. Cresset Asset Management LLC lifted its position in shares of Danaher by 14.8% during the 1st quarter. Cresset Asset Management LLC now owns 23,336 shares of the conglomerate’s stock worth $5,257,000 after buying an additional 3,017 shares during the period. Finally, Harbour Investments Inc. bought a new position in shares of Danaher during the 1st quarter worth approximately $259,000. 77.52% of the stock is owned by hedge funds and other institutional investors.

Shares of DHR opened at $295.86 on Thursday. The company has a market cap of $211.21 billion, a price-to-earnings ratio of 39.40, a PEG ratio of 1.93 and a beta of 0.70. Danaher Co. has a 52-week low of $211.22 and a 52-week high of $333.96. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.88 and a current ratio of 2.26. The stock has a fifty day moving average price of $316.49 and a two-hundred day moving average price of $278.87.

Danaher (NYSE:DHR) last released its earnings results on Thursday, July 22nd. The conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.05 by $0.41. The company had revenue of $7.22 billion during the quarter, compared to the consensus estimate of $6.71 billion. Danaher had a return on equity of 17.68% and a net margin of 21.00%. The firm’s quarterly revenue was up 36.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.44 earnings per share. As a group, research analysts predict that Danaher Co. will post 9.49 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 29th. Stockholders of record on Thursday, September 30th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Wednesday, September 29th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.28%. Danaher’s payout ratio is currently 13.31%.

Several equities analysts recently commented on DHR shares. The Goldman Sachs Group raised their target price on Danaher from $280.00 to $320.00 and gave the stock a “buy” rating in a research report on Friday, July 23rd. Cowen raised their target price on Danaher from $275.00 to $350.00 and gave the stock an “outperform” rating in a research report on Friday, July 23rd. Credit Suisse Group raised their target price on Danaher from $306.00 to $370.00 and gave the stock an “outperform” rating in a research report on Friday, September 10th. Benchmark initiated coverage on Danaher in a research report on Friday, July 16th. They set a “buy” rating and a $330.00 target price for the company. Finally, Zacks Investment Research upgraded Danaher from a “hold” rating to a “strong-buy” rating and set a $334.00 price objective for the company in a research report on Wednesday, July 28th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $321.53.

In related news, CAO Robert S. Lutz sold 5,000 shares of Danaher stock in a transaction on Friday, August 13th. The stock was sold at an average price of $313.40, for a total transaction of $1,567,000.00. Following the completion of the sale, the chief accounting officer now directly owns 21,155 shares of the company’s stock, valued at $6,629,977. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Joakim Weidemanis sold 16,467 shares of Danaher stock in a transaction on Tuesday, July 27th. The stock was sold at an average price of $289.45, for a total value of $4,766,373.15. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,477 shares of company stock valued at $15,439,958. 11.40% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines.

Read More: How Buying a Call Option Works

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.